Hyloris Pharmaceuticals SA (LON:0AB6)
London · Delayed Price · Currency is GBP · Price in EUR 7.58
-0.02 (-0.26%)
At close: Feb 11, 2026
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of 178.55 million as of February 12, 2026. Its market cap has increased by 39.05% in one year.
Market Cap
178.55M
Enterprise Value
163.33M
Revenue
7.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.58
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 224.34M to 178.55M, a decrease of -20.41%. That is a compound annual growth rate of -3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 183.60M | 9.89% |
| Dec 31, 2025 | 167.08M | 10.33% |
| Dec 31, 2024 | 151.44M | -51.12% |
| Dec 29, 2023 | 309.80M | 12.35% |
| Dec 30, 2022 | 275.75M | -26.54% |
| Dec 31, 2021 | 375.35M | 70.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CAB Payments Holdings | 195.47M |
| Vp plc | 193.58M |
| M&G Credit Income Investment Trust | 193.35M |
| John Wood Group | 184.97M |
| City of London Investment Group | 184.46M |
| Stelrad Group | 179.57M |
| Kistos Holdings | 177.53M |
| Regional REIT | 177.00M |